DESIREE PROVENCIO: Open Payments
NPI 1336648328 · ALBUQUERQUE, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 17 payments from 9 companies in 2025. Trend: 2023 $365 · 2024 $888 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $157 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $67 |
| ABBVIE INC. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: COBENFY, REXULTI, CAPLYTA, VRAYLAR, INGREZZA, UZEDY, Qelbree, Sunosi.
Industry payments across NM — which companies pay providers there.
